Similarly, oculomotor binocular dysfunction (HR 0.31, 95% CI: 0.160.60, p = 2 10 4 ), visual issues and blindness (HR 0.44, 95% CI: 0.260.76, p = 0.003), dry eye disease (HR 0.33, 95% CI: 0.150.71, p = 0.003), ametropic accommodative dysfunction (HR 0.31, 95% CI: 0.160.62, p = 2.3 10 4 ), and visual disturbances (HR 0.46, 95% CI: 0.260.83, p = 0.008) all showed statistically significant associations favoring Tirzepatide
**Dosing schedule:** Start at 2.5mg weekly, escalating every 4 weeks through 5mg, 7.5mg, 10mg, 12.5mg, up to 15mg (FDA approved)
Glutathione + Vitamin C IV
During this early stage, visible improvements become noticeable to patients by the end of their first month on semaglutide
Its also not considered a first-line treatment for blood sugar issues
But is there a grain of truth behind all the hype